Product Information
DEXTROAMP-AMPHET ER 25 MG CAP is a generic product labeled by Elite Laboratories, Inc., priced at $0.4952 per EA under NDC 64850051401. Its NADAC has been published 168 times since Jun 7, 2023.
FDA first approved this application on Dec 11, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHET ER 25 MG CAP
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine SulfateStrength
6.25; 6.25; 6.25; 6.25 mg/1; mg/1; mg/1; mg/1
Manufacturer
Elite Laboratories, Inc.NDC
64850051401
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA212037FDA Approved
12/11/2019
TE Code
AB1
On Market Since
12/16/2019
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has been published 168 times since Jun 7, 2023, and over the history we have for it it has declined 28.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4952 per EA |
|---|---|
| All-time high | $0.7537 (Mar 12, 2025) |
| All-time low | $0.4173 (May 22, 2024) |
| 52-week high | $0.5709 |
| 52-week low | $0.4896 |
| Median price | $0.5682 |
| Average price | $0.5858 |
| Largest weekly change | +30.3% (Dec 18, 2024) |
| Weeks tracked | 168 |
| Tracking since | Jun 7, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 25 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 25 MG CAP, manufactured by Elite Laboratories, Inc., is $0.4952 per EA (NDC 64850051401), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHET ER 25 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has declined 28.7%. It has been tracked across 168 weekly CMS publications since Jun 7, 2023.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 25 MG CAP?
Since Jun 7, 2023, the NADAC for DEXTROAMP-AMPHET ER 25 MG CAP has ranged from a low of $0.4173 (May 22, 2024) to a high of $0.7537 (Mar 12, 2025), with a median of $0.5682 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 25 MG CAP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DEXTROAMP-AMPHET ER 25 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXTROAMP-AMPHET ER 25 MG CAP?
DEXTROAMP-AMPHET ER 25 MG CAP (NDC 64850051401) is labeled by Elite Laboratories, Inc., and CMS classifies it as a generic product.